Inventor · disambiguated record
A. Martin Lerner
Also filed as: LERNER A MARTIN
8 granted patents·2 pending applications·50 citations·filing 1981–2016
85Inventor score
Top patents by PatentIndex Score
10 records- 0177US4389395ALow molecular weight complex of polyriboinosinic-polyribocytidylic acid and method of inducing interferonLERNER A MARTIN·Filed 1981·Granted Jun 21, 1983·22 cites·8 claims
- 0268US6894056B2Method for diagnosing and alleviating the symptoms of chronic fatigue syndromeFiled 2002·Granted May 17, 2005·2 cites·10 claims
- 0368US6537997B1Method for diagnosing and alleviating the symptoms of chronic fatigue syndromeFiled 2000·Granted Mar 25, 2003·2 cites·13 claims
- 0467US6399622B1Method for diagnosing and alleviating the symptoms of chronic fatigue syndromeFiled 2001·Granted Jun 4, 2002·2 cites·2 claims
- 0563US10215755B2Method of diagnosing and treating Epstein Barr virus-based myalgic encephalomyelitis chronic fatigue syndrome patientsCFS LLC·Filed 2015·Granted Feb 26, 2019·1 cites·15 claims
- 0645US6258818B1Method for diagnosing and alleviating the symptoms of chronic fatigue syndromeFiled 1998·Granted Jul 10, 2001·9 cites·14 claims
- 0745US2014100238A1Method of diagnosing and treating epstein barr virus-based myalgic encephalomyelitis chronic fatigue syndrome patientsCFS LLC·Filed 2012·Application pending·0 cites
- 0841US5872123AMethod for diagnosing and alleviating the symptoms of chronic fatigue syndromeFiled 1997·Granted Feb 16, 1999·6 cites·14 claims
- 0939US5677308AMethod for alleviating spasmodic torticollisFiled 1996·Granted Oct 14, 1997·6 cites·12 claims
- 1031US2016258954A1Method of diagnosing and treating epstein barr virus-based myalgic encephalomyelitis chronic fatigue syndrome patients using a serum antibody assayCFS LLC·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when A. Martin Lerner files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →